2025 annual financial data
Cue Biopharma 2025 Net margin
Direct answer
Net margin was -96.85%.
Operating income was -26,521,000 USD and net income was -26,602,000 USD.
Operating cash flow was -21,687,000 USD.
Get free Cue Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,466,000 USD
- Operating income
- -26,521,000 USD
- Net income
- -26,602,000 USD
- Operating cash flow
- -21,687,000 USD